Velocity’s Van Nuys research site was founded as the National Research Institute, a five site research network in southern California, and acquired by Velocity in 2021. The Van Nuys site offers a wide range of expertise including diabetes, NASH, vaccines, psychiatry, women’s health, and pediatric trials. Van Nuys’ experienced staff maintains high quality standards and enrollment on all their trials.
Located outside of Los Angeles, the Van Nuys site is easily accessible for patients through public transport. The Van Nuys team is bilingual allowing the site to recruit a diverse patient population. The local hospital is located less than a mile away.
All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Van Nuys team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.